INDICATION AND LIMITATION OF USE

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

This site is intended for US healthcare professionals only.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

IMPORTANT SAFETY INFORMATION    This site is intended for US healthcare professionals only.

WARNING: ABUSE AND DEPENDENCE

  • | CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Tips to Help Assess for ADHD in Adults

While there is no simple test to diagnose ADHD, in recent years, there has been growing recognition of ADHD in adults and more specific examples of adult symptoms are now included in the DSM-5®.1,2

An assessment of ADHD in adult patients, using age-appropriate and open-ended questions, while referring to the DSM-5® criteria, may help yield a more in-depth assessment of their symptoms.³

Tips for Breaking the Barriers

Obtaining feedback from friends, family members, teachers, and/or co-workers of your ADHD patient is essential to effective ADHD assessment.

The content of an ADHD assessment should be based on the DSM-5® diagnostic criteria for ADHD and may include the evaluation of the following:

  • ADHD symptoms2
  • Associated conditions and comorbidities2
  • Impairment in daily activities2
    • At home
    • At school/workplace
    • In social settings
  • Family ADHD/psychiatric history2,4
  • Past medical history4
  • Patient and family understanding of ADHD and their beliefs5
  • Potential barriers to management6

Consider these questions:

  • What symptoms have you or others observed?
  • How often do symptoms appear during the day?
  • Do you or others notice certain situations that provoke symptoms?
  • Do you or others notice a time of day when symptoms are more pronounced?
“In most individuals with ADHD, symptoms of motoric hyperactivity become less obvious in adolescence and adulthood, but difficulties with restlessness, inattention, poor planning, and impulsivity persist.”
—American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM-5®)

You are about to leave vyvansepro.com.

Please be advised that Shire has no control over the content or presentation of the site you are about to view.

Cancel Continue
CLOSE
Scroll for additional Important Safety Info & see Full Prescribing Information.